Wilson Sonsini Goodrich & Rosati advised Tenaya on the deal, while Davis Polk advised the joint book-running managers and representatives of the several underwriters. Clinical stage...
Tenaya Therapeutics’ $75 Million Shares Offering
Recursion Pharmaceuticals’ $150 Million Private Placement
Davis Polk advised the placement agents in the transaction. Recursion Pharmaceuticals executed its $150 million private placement of common stock. Morgan Stanley & Co. LLC acted as the...
ChargePoint Holdings’ $500 Million At-The-Market Offering
Davis Polk advised the sales agents in the offering. ChargePoint Holdings, Inc. finalized a $500 million SEC-registered at-the-market offering of its common stock. ChargePoint’s common stock is...